“immunotherapy” Archives

in
Entry Author Date Location
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy 01/31/20 San Francisco
Incyte Commits $900M to MorphoSys for Rights to Lymphoma Drug 01/13/20 National
Merck Ramps Up KRAS Chase Through Licensing Deal With Taiho, Astex 01/06/20 New York
No More Fish or Fruit: Intrexon Turns SynBio Focus to Human Health 01/02/20 National
Scripps Research, AbbVie Expand Drug Discovery Deal Beyond Cancer 12/10/19 San Diego
Roche Notches FDA Nod in Lung Cancer, Amps Up Competition With Merck 12/04/19 San Francisco
Ferring and Blackstone Team Up to Fund Gene Therapy Firm With $570M 11/25/19 Boston
ArsenalBio Launches With $85M for “Programmable” T Cell Therapies 10/17/19 San Francisco
Eli Lilly Drug Acquired in Armo Deal Fails Pancreatic Cancer Test 10/16/19 Indiana
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More 10/01/19 National
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More 09/27/19 National
Gilliland to Step Down as Head of Fred Hutch in 2020 09/17/19 Seattle
FDA Doesn’t Shell Peanut Allergy Drug Pre-Hearing, Aimmune Shares Climb 09/11/19 San Francisco
Herceptin Inventors, Immunology Pioneers Take Home 2019 Lasker Awards 09/10/19 National
At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More 09/09/19 National
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone 09/06/19 National
Oncorus Adds $79.5M to Steer Cancer-Fighting Virus to Human Testing 08/21/19 Boston
Four New Drugs Are Around the Corner. Here’s What You Need to Know. 08/15/19 National
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More 08/02/19 National
Merck Data Are Another Step for Immunotherapy in Breast Cancer 07/29/19 New York
Bristol, With Another Lung Cancer Flop, Loses More Ground to Merck 07/24/19 New York
Neon’s Early Vaccine Study Is a Peek at Immunotherapy’s Third Wave 07/15/19 Boston
Bio Roundup: Merger Drama, FDA Trauma, Big IPOs, CRISPR Fights & More 06/28/19 National
Mirati Stock Sale Targets $200M as Lead Cancer Drug Starts Phase 3 06/26/19 San Diego
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer 06/19/19 San Diego
Bio Roundup: Roche-Spark Drags On, GSK Taps CRISPR, Diabetes News & More 06/14/19 National
Merck Bags Tilos, Adding an Immunotherapy Booster to Its Arsenal 06/10/19 Boston
Bio Roundup: ASCO Wrap, Bluebird’s EU Tap, CRISPR Baby Risk & More 06/07/19 National
ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More 06/05/19 National
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer? 05/30/19 National
Page 1 of 9 next page »